Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane
Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane
Subject
:
Ophthalmology
Document Language
:
English
Abstract
:
Vogt-Koyanagi-Harada syndrome is a bilateral granulomatous panuveitis with central nervous system, auditory, and integumentary manifestations.1,2 Typically, ocular involvement is associated with choroidal lesions, exudative retinal detachments, and optic nerve inflammation.2 Treatment usually requires high-dose systemic corticosteroids and immunosuppressive agents.1,2 Resolution without visually significant sequelae may occur, but complications, including cataract, glaucoma, and choroidal neovascular membrane formation, are not infrequent
ISSN
:
0008-4182
Journal Name
:
Canadian Journal of Ophthalmology
Volume
:
44
Issue Number
:
5
Publishing Year
:
1430 AH
2009 AD
Article Type
:
Case Report
Added Date
:
Tuesday, August 2, 2011
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
لينا رفه
Raffa, Lina
Investigator
أحمد باوزير
Bawazeer, Ahmed
Researcher
Doctorate
Files
File Name
Type
Description
29997.pdf
pdf
Back To Researches Page